Home LiteratureArticle Details
PMID: 20208016 Published · ppublish English Editorial Research Support, N.I.H., Extramural Comment

Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology.

Journal of the National Cancer Institute ·Vol. 102 ·No. 6 ·2010-03-17 ·Pages 365-7

Ogino S, Stampfer M

Abstract

暂无摘要

MeSH Terms
Body Mass Index Case-Control Studies Colorectal Neoplasms/epidemiology,etiology,genetics,pathology Confounding Factors, Epidemiologic Humans Life Style Microsatellite Instability Odds Ratio Predictive Value of Tests Risk Assessment Risk Factors Selection Bias Sensitivity and Specificity
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Ogino Shuji
Stampfer Meir
References (50)
50 references, click to expand
  1. Body size and the risk of colon cancer in a large case-control study.
    Int J Obes Relat Metab Disord. 1998 Feb;22(2):178-84 PMID: 9504326
  2. Physical activity, obesity, and risk for colon cancer and adenoma in men.
    Ann Intern Med. 1995 Mar 1;122(5):327-34 PMID: 7847643
  3. CpG island methylator phenotype in colorectal cancer.
    Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681-6 PMID: 10411935
  4. Dietary folate intake and k-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study.
    Int J Cancer. 2005 May 1;114(5):824-30 PMID: 15609319
  5. Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study.
    Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):429-36 PMID: 15734969
  6. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer.
    Gastroenterology. 2005 Sep;129(3):837-45 PMID: 16143123
  7. Effect of physical activity and body size on survival after diagnosis with colorectal cancer.
    Gut. 2006 Jan;55(1):62-7 PMID: 15972299
  8. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer.
    Nat Genet. 2006 Jul;38(7):787-93 PMID: 16804544
  9. Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use.
    Cancer Res. 2006 Jul 1;66(13):6877-83 PMID: 16818666
  10. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
    J Natl Cancer Inst. 2006 Nov 15;98(22):1647-54 PMID: 17105987
  11. Dietary folate and APC mutations in sporadic colorectal cancer.
    J Nutr. 2006 Dec;136(12):3015-21 PMID: 17116713
  12. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.
    Int J Cancer. 2007 Feb 1;120(3):656-63 PMID: 17096326
  13. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.
    J Natl Cancer Inst. 2006 Dec 6;98(23):1731-8 PMID: 17148775
  14. APC mutations and other genetic and epigenetic changes in colon cancer.
    Mol Cancer Res. 2007 Feb;5(2):165-70 PMID: 17293392
  15. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
    Hum Pathol. 2007 Jun;38(6):842-9 PMID: 17350669
  16. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.
    N Engl J Med. 2007 May 24;356(21):2131-42 PMID: 17522398
  17. Dietary fat and risk of colon and rectal cancer with aberrant MLH1 expression, APC or KRAS genes.
    Cancer Causes Control. 2007 Oct;18(8):865-79 PMID: 17636402
  18. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women.
    Cancer Res. 2007 Aug 1;67(15):7534-9 PMID: 17671225
  19. Folic acid and vitamin B-12 supplementation does not favorably influence uracil incorporation and promoter methylation in rectal mucosa DNA of subjects with previous colorectal adenomas.
    J Nutr. 2007 Sep;137(9):2114-20 PMID: 17709451
  20. Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.
    Neoplasia. 2007 Jul;9(7):569-77 PMID: 17710160
  21. Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 adipocytes: a role for oxidant stress.
    J Biol Chem. 2007 Sep 14;282(37):26793-801 PMID: 17635921
  22. Molecular classification and correlates in colorectal cancer.
    J Mol Diagn. 2008 Jan;10(1):13-27 PMID: 18165277
  23. Targeted therapy of cancer: new roles for pathologists in colorectal cancer.
    Mod Pathol. 2008 May;21 Suppl 2:S23-30 PMID: 18437170
  24. Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype.
    Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1774-80 PMID: 18628431
  25. Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression.
    Gastroenterology. 2008 Sep;135(3):770-80 PMID: 18619459
  26. A prospective study of dietary folate and vitamin B and colon cancer according to microsatellite instability and KRAS mutational status.
    Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2895-8 PMID: 18843035
  27. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.
    PLoS One. 2008;3(11):e3698 PMID: 19002263
  28. Obesity enhances gastrointestinal tumorigenesis in Apc-mutant mice.
    Int J Obes (Lond). 2008 Nov;32(11):1716-9 PMID: 18725892
  29. Cohort study of fatty acid synthase expression and patient survival in colon cancer.
    J Clin Oncol. 2008 Dec 10;26(35):5713-20 PMID: 18955444
  30. Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors.
    Gut. 2009 May;58(5):661-7 PMID: 18523027
  31. Somatic alterations, metabolizing genes and smoking in rectal cancer.
    Int J Cancer. 2009 Jul 1;125(1):158-64 PMID: 19358278
  32. A cohort study of p27 localization in colon cancer, body mass index, and patient survival.
    Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1849-58 PMID: 19505918
  33. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Am J Gastroenterol. 2009 Jul;104(7):1790-801 PMID: 19491830
  34. Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer.
    Clin Cancer Res. 2009 Jul 15;15(14):4665-73 PMID: 19584150
  35. A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.
    Am J Gastroenterol. 2009 Aug;104(8):2047-56 PMID: 19513025
  36. Aspirin use and survival after diagnosis of colorectal cancer.
    JAMA. 2009 Aug 12;302(6):649-58 PMID: 19671906
  37. p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis.
    Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2513-21 PMID: 19723919
  38. Interaction of molecular markers and physical activity on mortality in patients with colon cancer.
    Clin Cancer Res. 2009 Sep 15;15(18):5931-6 PMID: 19723652
  39. Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status.
    Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2745-50 PMID: 19755657
  40. Early life exposure to famine and colorectal cancer risk: a role for epigenetic mechanisms.
    PLoS One. 2009;4(11):e7951 PMID: 19956740
  41. Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry.
    Mol Genet Metab. 2010 Feb;99(2):157-9 PMID: 19853488
  42. One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case-referent study.
    Cancer Causes Control. 2010 Apr;21(4):557-66 PMID: 20012180
  43. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status.
    J Natl Cancer Inst. 2010 Mar 17;102(6):391-400 PMID: 20208017
  44. Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer.
    Gut. 2010 Jun;59(6):794-9 PMID: 19828464
  45. AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes.
    J Biol Chem. 1998 Jun 12;273(24):14767-71 PMID: 9614076
  46. Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas.
    Cancer Res. 1999 Oct 15;59(20):5181-5 PMID: 10537295
  47. Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study.
    Cancer Res. 2000 Dec 15;60(24):6935-41 PMID: 11156393
  48. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors.
    J Natl Cancer Inst. 2000 Nov 15;92(22):1831-6 PMID: 11078760
  49. Lifestyle factors and Ki-ras mutations in colon cancer tumors.
    Mutat Res. 2001 Nov 1;483(1-2):73-81 PMID: 11600135
  50. Dietary factors and microsatellite instability in sporadic colon carcinomas.
    Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1130-6 PMID: 14652271
Article Info
Journal
Journal of the National Cancer Institute
Abbr.
J Natl Cancer Inst
ISSN
1460-2105
DOI
10.1093/jnci/djq031
Published
2010-03-17
Epub
2010-00-05
Pages
365-7
Language
English
Region
United States
NLM ID
7503089
PMCID
PMC2841039
Subset
IM
Grants
NCI NIH HHS · K07 CA122826 · United States
NCI NIH HHS · P01 CA55075 · United States
NCI NIH HHS · P01 CA87969 · United States
Corrections
CommentOn
PMID: 20208017
External Links
PubMed source DOI: 10.1093/jnci/djq031 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2